---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

You can also find my articles on <a href="{{site.author.googlescholar}}">my Google Scholar profile</a>.</div>


**_Papers_**
*  Liu Z*, Yang N*, **Dong J\***, et al. Deficiency in endocannabinoid synthase DAGLB contributes to Parkinson's disease and dopaminergic neuron dysfunction[J]. _Nature Communication_, 2022, 13(1):1-16. (***Co-first authors**) [[paper link](https://www.nature.com/articles/s41467-022-31168-9)]

*  **Dong J**, Hawes S, Wu J, et al. Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease[J]. _Frontiers in Neural Circuits_, 2021, 15: 8. [[paper link](https://www.frontiersin.org/journals/neural-circuits/articles/10.3389/fncir.2021.645287/full)]

*  **Dong J**, Liu X, Wang Y, et al. Nurr1Cd11bcre conditional knockout mice display inflammatory injury to nigrostriatal dopaminergic neurons[J]. _Glia_, 2020; 1-13. [[paper link](https://onlinelibrary.wiley.com/doi/10.1002/glia.23826)]

*  Wu J B, Kung J, **Dong J**, et al. Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning[J]. _Cell reports_, 2019, 28(5): 1167-1181. [[paper link](https://www.cell.com/cell-reports/fulltext/S2211-1247(19)30881-2)]

*  **Dong J**, Cui Y, Li S, et al. Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease[J]. _Current Neuropharmacology_, 2016, 14(4): 339-355. [[paper link](https://www.eurekaselect.com/article/72015)]

*  Le W*, **Dong J\***, Li S, et al. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease? [J]. _Neuroscience Bulletin_, 2017, 33(5):535. (***Co-first authors**) [[paper link](https://link.springer.com/article/10.1007/s12264-017-0174-6)]

*  **Dong J**, Li S, Mo J L, et al. Nurr1-Based Therapies for Parkinson's Disease[J]. _CNS neuroscience & therapeutics_, 2016, 22(5): 351-359. [[paper link](https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.12536)]

* Li S*, **Dong J\***, Cheng C, et al. Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions[J]. _Journal of Neural Transmission_, 2016, 123(11): 1279-1299. (***Co-first author**) [[paper link](https://link.springer.com/article/10.1007/s00702-016-1603-9)]

* Liu XY*, **Dong J\***, Le WD. Cell therapy for Parkinson’s disease[J]. _Translational Medicine Journal_, 2018(7):334-337. (***Co-first author**) 

* **Dong J**, Li S, Le WD. Research progress of dopamine agonists in neurological and psychiatric disorders[J]. _Chinese Journal of New Drugs and Clinical Remedies_, 2016(2):90-97. (in Chinese)
 
* **Dong J**, Li F. The role of CXCR12 and its receptors in non-small cell lung cancer with brain metastasis[J]. _Zhong Guo Mian Yi Xue Za Zhi_, 2015(8):1147-1150. (in Chinese)


**_Book Chapter_**

* **Dong J**, Chen S, Le WD. Nr4a subfamily. Edited by Katie Kompolti, Leonard Verhagen. _In The Curated Reference Collection in Neuroscience and Biobehavioral Psychology_ [M]. 2nd ed. Elsevier Science, 2017. [[paper link](https://www.sciencedirect.com/science/article/abs/pii/B9780128093245007100?via%3Dihub)]
 
